UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Associations of chronic hepatitis C with metabolic and cardiac outcomes

Alimentary pharmacology & therapeutics, 2013-03, Vol.37 (6), p.647-652

2013

Volltextzugriff (PDF)

A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection

Journal of viral hepatitis, 2015-11, Vol.22 (11), p.897-905

2015

Volltextzugriff (PDF)

The impact of hepatitis C burden: an evidence‐based approach

Alimentary pharmacology & therapeutics, 2014-03, Vol.39 (5), p.518-531

2014

Volltextzugriff (PDF)

Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in patients with chronic hepatitis C

Alimentary pharmacology & therapeutics, 2013-04, Vol.37 (7), p.703-709

2013

Volltextzugriff (PDF)

Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan

Journal of viral hepatitis, 2018-08, Vol.25 (8), p.945-951

2018

Volltextzugriff (PDF)

Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus

Journal of viral hepatitis, 2016-11, Vol.23 (11), p.857-865

2016

Volltextzugriff (PDF)

Patients' preferences and health utility assessment with SF‐6D and EQ‐5D in patients with chronic hepatitis C treated with sofosbuvir regimens

Alimentary pharmacology & therapeutics, 2014-09, Vol.40 (6), p.676-685

2014

Volltextzugriff (PDF)

Association of work productivity with clinical and patient-reported factors in patients infected with hepatitis C virus

Journal of viral hepatitis, 2016-08, Vol.23 (8), p.623-630

2016

Volltextzugriff (PDF)

Cost‐effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection

Alimentary pharmacology & therapeutics, 2014-09, Vol.40 (6), p.657-675

2014

Volltextzugriff (PDF)

Real‐world effectiveness for 12 weeks of ledipasvir–sofosbuvir for genotype 1 hepatitis C: the Trio Health study

Journal of viral hepatitis, 2017-01, Vol.24 (1), p.22-27

2017

Volltextzugriff (PDF)

Direct medical costs associated with the extrahepatic manifestations of hepatitis C virus infection in France

Alimentary Pharmacology & Therapeutics (Suppl), 2018-01, Vol.47 (1), p.123-128

2018

Volltextzugriff (PDF)

The impact of chronic hepatitis C on resource utilisation and in‐patient mortality for Medicare beneficiaries between 2005 and 2010

Alimentary pharmacology & therapeutics, 2013-11, Vol.38 (9), p.1065-1075

2013

Volltextzugriff (PDF)

Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO network

Journal of viral hepatitis, 2016-06, Vol.23 (6), p.447-454

2016

Volltextzugriff (PDF)

Direct medical costs associated with the extrahepatic manifestations of hepatitis C infection in Europe

Journal of viral hepatitis, 2018-07, Vol.25 (7), p.811-817

2018

Volltextzugriff (PDF)

Health‐related quality of life in genotype 1 treatment‐naïve chronic hepatitis C patients receiving telaprevir combination treatment in the ADVANCE study

Alimentary pharmacology & therapeutics, 2013-07, Vol.38 (2), p.124-133

2013

Volltextzugriff (PDF)

Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity

Journal of viral hepatitis, 2012-05, Vol.19 (5), p.341-345

2012

Volltextzugriff (PDF)

Knowledge about infection is the only predictor of treatment in patients with chronic hepatitis C

Journal of viral hepatitis, 2013-08, Vol.20 (8), p.550-555

2013

Volltextzugriff (PDF)

Ledipasvir/sofosbuvir treatment of hepatitis C virus is associated with reduction in serum apolipoprotein levels

Journal of viral hepatitis, 2015-12, Vol.22 (12), p.977-982

2015

Volltextzugriff (PDF)

Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries

Journal of viral hepatitis, 2016-03, Vol.23 (3), p.217-226

2016

Volltextzugriff (PDF)

Quality of life in adolescents with hepatitis C treated with sofosbuvir and ribavirin

Journal of viral hepatitis, 2018-04, Vol.25 (4), p.354-362

2018

Volltextzugriff (PDF)

Long‐term trends in chronic hepatitis B virus infection associated liver transplantation outcomes in the United States

Journal of viral hepatitis, 2017-09, Vol.24 (9), p.789-796

2017

Volltextzugriff (PDF)

Inpatient resource utilization, disease severity, mortality and insurance coverage for patients hospitalized for hepatitis C virus in the United States

Journal of viral hepatitis, 2015-02, Vol.22 (2), p.137-145

2015

Volltextzugriff (PDF)

Sofosbuvir and simeprevir combination therapy in the setting of liver transplantation and hemodialysis

Transplant infectious disease, 2015-04, Vol.17 (2), p.275-278

2015

Volltextzugriff (PDF)

Impact of ledipasvir/sofosbuvir on the work productivity of genotype 1 chronic hepatitis C patients in Asia

Journal of viral hepatitis, 2018-03, Vol.25 (3), p.228-235

2018

Volltextzugriff (PDF)

Screening for hepatitis B, C and non‐alcoholic fatty liver disease: a survey of community‐based physicians

Alimentary pharmacology & therapeutics, 2009-05, Vol.29 (9), p.1019-1024

2009

Volltextzugriff (PDF)

1 – 25 von 49

Suche als RSS-Feed

Aktive Filter

ThemaInfectious Diseases

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(42)

Publikationsform

Artikel
(49)

Sprache

Englisch
(49)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(47)
Science & Technology
(47)
Humans
(42)
Gastroenterology & Hepatology
(41)
Middle Aged
(37)
Male
(36)
Female
(35)
Adult
(32)
Biological And Medical Sciences
(26)
Medical Sciences
(26)
Human Viral Diseases
(25)
Viral Diseases
(25)
Viral Hepatitis
(25)
Virology
(21)
Aged
(20)
Hepatitis C, Chronic - Drug Therapy
(20)
Hepatitis C Virus
(19)
Antiviral Agents - Therapeutic Use
(18)
Hepatitis C
(16)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Associations of chronic hepatitis C with metabolic and cardiac outcomes

A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis C virus infection

The impact of hepatitis C burden: an evidence‐based approach

Moderate, excessive or heavy alcohol consumption: each is significantly associated with increased mortality in patients with chronic hepatitis C

Treatment of hepatitis C virus leads to economic gains related to reduction in cases of hepatocellular carcinoma and decompensated cirrhosis in Japan

Sofosbuvir and ledipasvir improve patient-reported outcomes in patients co-infected with hepatitis C and human immunodeficiency virus

Patients' preferences and health utility assessment with SF‐6D and EQ‐5D in patients with chronic hepatitis C treated with sofosbuvir regimens

Association of work productivity with clinical and patient-reported factors in patients infected with hepatitis C virus

Cost‐effectiveness analysis of sofosbuvir plus peginterferon/ribavirin in the treatment of chronic hepatitis C virus genotype 1 infection

Real‐world effectiveness for 12 weeks of ledipasvir–sofosbuvir for genotype 1 hepatitis C: the Trio Health study

Direct medical costs associated with the extrahepatic manifestations of hepatitis C virus infection in France

The impact of chronic hepatitis C on resource utilisation and in‐patient mortality for Medicare beneficiaries between 2005 and 2010

Disparate access to treatment regimens in chronic hepatitis C patients: data from the TRIO network

Direct medical costs associated with the extrahepatic manifestations of hepatitis C infection in Europe

Health‐related quality of life in genotype 1 treatment‐naïve chronic hepatitis C patients receiving telaprevir combination treatment in the ADVANCE study

Association of hepatitis C with insulin resistance and type 2 diabetes in US general population: the impact of the epidemic of obesity

Knowledge about infection is the only predictor of treatment in patients with chronic hepatitis C

Ledipasvir/sofosbuvir treatment of hepatitis C virus is associated with reduction in serum apolipoprotein levels

Impact of eradicating hepatitis C virus on the work productivity of chronic hepatitis C (CH-C) patients: an economic model from five European countries

Quality of life in adolescents with hepatitis C treated with sofosbuvir and ribavirin

Long‐term trends in chronic hepatitis B virus infection associated liver transplantation outcomes in the United States

Inpatient resource utilization, disease severity, mortality and insurance coverage for patients hospitalized for hepatitis C virus in the United States

Sofosbuvir and simeprevir combination therapy in the setting of liver transplantation and hemodialysis

Impact of ledipasvir/sofosbuvir on the work productivity of genotype 1 chronic hepatitis C patients in Asia

Screening for hepatitis B, C and non‐alcoholic fatty liver disease: a survey of community‐based physicians

Aktive Filter

Suchergebnisse filtern